Paulo R Shiroma
Minneapolis VA Health Care System, Minneapolis, MN · Minneapolis Veterans Affairs Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Paulo R Shiroma as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:15 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04560660 · Ketamine-enhanced Prolonged Exposure Therapy in PTSDVA Office of Research and Development · completed · PTSD · principal investigator
- Ph1/Ph2NCT03960658 · Ketamine and Prolonged Exposure in PTSDMinneapolis Veterans Affairs Medical Center · completed · Post-traumatic Stress Disorder · principal investigator
- Ph2NCT02360280 · Efficacy of Repeated Ketamine Infusions for Treatment-resistant DepressionVA Office of Research and Development · completed · Treatment-resistant Depression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSDI01CX001803 · VA · MINNEAPOLIS VA MEDICAL CENTER · fiscal years 2021 to 2025Same name and institution; not confirmed by an ID
- Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant DepressionI01CX001191 · VA · MINNEAPOLIS VA MEDICAL CENTER · fiscal years 2015 to 2018Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:15 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.J Clin Psychiatry · 2018116 citationsRCR 6.1
- A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression.Transl Psychiatry · 202090 citationsRCR 5.1
- Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.Neuropsychopharmacology · 202290 citationsRCR 9.2
- Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression.J Affect Disord · 202035 citationsRCR 2.3
- The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use.J Clin Psychiatry · 201733 citationsRCR 1.6
- SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.Am J Geriatr Psychiatry · 201414 citationsRCR 0.6